NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

NDA Partners was founded in 2003 by a group of ten former senior regulatory agency staff, pharmaceutical industry executives, and academic experts who have played a major role in medical product development, drug regulations and program management over the past several decades. The company has focused on improving the development efficiency and speed and commercial success rate of medical products since its founding. A formal methodology was developed (Principles of Optimal Product Development) to provide high-level guidance for conducting strategic and assessment-orientated engagements. Originally, our customers were emerging biopharmaceutical companies and life sciences investment funds, and our services now include international pharma companies entering the US market, law firms involved in medical product litigation, research and development-oriented government agencies, and health care organizations.


Fritz Buhler, MD
Alex Cross, PhD, DSc, FRSC
Dennis Fisher, MD
Charles Grudzinskas, PhD
Earle Martin
Carl Peck, MD
Malcolm Rowland, PhD
David Savello, PhD
George Schwartz
Lewis Sheiner, MD